Clinical trial
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
NCT01939691 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 12, 2018
- Completion date
- March 31, 2020
- Enrollment
- 9 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.